IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices

Patients undergoing heart transplantation (HTx) with active infection of left ventricular assist devices (LVAD) are at high risk for postoperative infections. Between 2021 and 2022, five (P1–P5) of a total of n = 44 patients underwent HTx in our department while suffering from LVAD infection. Postop...

Descripción completa

Detalles Bibliográficos
Autores principales: Immohr, Moritz Benjamin, Böttger, Charlotte, Aubin, Hug, Westenfeld, Ralf, Oehler, Daniel, Bruno, Raphael Romano, Dalyanoglu, Hannan, Tudorache, Igor, Akhyari, Payam, Lichtenberg, Artur, Boeken, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715847/
https://www.ncbi.nlm.nih.gov/pubmed/35854478
http://dx.doi.org/10.1002/ehf2.14074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715847/
https://www.ncbi.nlm.nih.gov/pubmed/35854478
http://dx.doi.org/10.1002/ehf2.14074

Ejemplares similares